Eniclobrate

This classification denotes an anti-lipidemic agent with the molecular formula C24H24ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M469UFX48N, chemically known as butanoic acid, 2-(4-((4-chlorophenyl)methyl)phenoxy)-2-methyl-, 3-pyridinylmethyl ester, (+-)- but generally known as eniclobrate, which bears US NIH Compound Identifier 43387. European Medicines Agency schedules Eniclobrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06532MIG. The term ENICLOBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). ENICLOBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eniclobrate under HS 29333999 and SITC 51574. As of Q4 2014, ENICLOBRATE remains the US FDA Preferred Term for this commodity. Eniclobrate bears US NLM identifiers UMLS ID C0059300 and NCI Concept Code C72992. SMILES: Clc1ccc(Cc2ccc(OC(CC)(C)C(=O)OCc3cccnc3)cc2)cc1.